Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors

Table 3

Diagnostic performance of gene expressions in predicting head and neck malignant tumors.

Gene	Cut-off	AUC	Sensitivity (%)	Specificity (%)	PPV (%)	NPV (%)	value
EGFR	≥3.40	0.901	86.4	82.7	78.0	84.2	<0.001

AUC: area under curve; SENS: sensitivity; SPEC: specificity; PPV: positive predictive value; NPV: negative predictive value.